Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Current Role of Antiangiogenics in Colorectal Cancer. | Int J Mol Sci | 2025 | 41373757 | PubTator, text mining | PubMed |
| Context-aware gene dependency modeling via graph attention networks for precision oncology. | J Transl Med | 2025 | 41291726 | PubTator, text mining | PubMed |
| Coverage of actionable alterations in non-small cell lung cancer by hybrid capture-based FoundationOne®CDx compared with amplicon-based OncomineDX. | Oncologist | 2025 | 41264468 | PubTator, text mining | PubMed |
| Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report. | Front Immunol | 2025 | 41208980 | PubTator, text mining | PubMed |
| Clinical Actionability of Genes in Gastrointestinal Tumors. | Genes (Basel) | 2025 | 41153346 | PubTator, text mining | PubMed |
| [A Case of MSI‒Stable Rectal Cancer with Para‒Aortic Lymph Node Metastasis Treated by Sequential Therapy with Standard Treatment and Immune Checkpoint Inhibitors]. | Gan To Kagaku Ryoho | 2025 | 41139978 | PubTator, text mining | PubMed |
| [A Case of Cecal‒Ascending Colon Cancer Achieved Complete Remission by Surgical Resection and Immune Checkpoint Inhibitor]. | Gan To Kagaku Ryoho | 2025 | 41139973 | PubTator, text mining | PubMed |
| Imagery and motivation in performance sports: a psychological study on weightlifters. | BMC Psychol | 2025 | 41131555 | PubTator, text mining | PubMed |
A Machine Learning-Based Scoring System to Identify High Immunoactivity Microsatellite Stability Tumors by Quantifying Similarity to Microsatellite Instability-High Tumors in Colorectal Cancers: Development and Quantitative Study. | JMIR Form Res | 2025 | 41100766 | PubTator, text mining | PubMed |
| Prognosis in stage II colorectal cancer: the effect of the primary tumor location and biomarkers-a retrospective cohort study. | Oncologist | 2025 | 41060013 | PubTator, text mining | PubMed |
| Adjuvant Chemotherapy and Survival in MSI-High Stages II and III Colon Cancer: Impact of Histopathologic Risk Stratification. | Ann Surg Oncol | 2025 | 41057742 | PubTator, text mining | PubMed |
| Adenocarcinoma Around the Esophagogastric Junction Mimicking Submucosal Tumors: A Case Report. | Cureus | 2025 | 41050019 | PubTator, text mining | PubMed |
| Bringing immunotherapy to clinical practice in dMMR/MSI-high colon cancer. | Cancer Cell | 2025 | 41043436 | PubTator, text mining | PubMed |
| Trimmed N-glycans define aggressive gastric cancer and predict clinical outcomes. | Theranostics | 2025 | 41041068 | PubTator, text mining | PubMed |
| Regulatory influence of α-Pinene on MATN3 expression in hepatocellular carcinoma: Extending to pan-cancer analysis. | PLoS One | 2025 | 41004439 | PubTator, text mining | PubMed |
| Can non-tumorous liver tissue serve as a reliable reference measure for [18F]FDG-PET-CT after unilobar 90Y glass radioembolization in patients with colorectal liver metastases? | EJNMMI Res | 2025 | 41003938 | PubTator, text mining | PubMed |
| Microsatellite Instability and Myometrial Infiltration in Low-Grade Endometrial Cancer: A Focus on MMR Heterodimer Dysfunction by a Retrospective Multicentric Italian Study. | J Pers Med | 2025 | 41003120 | PubTator, text mining | PubMed |
| CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy. | BMC Cancer | 2025 | 40993621 | PubTator, text mining | PubMed |
| Requirements for establishment and epigenetic stability of mammalian heterochromatin. | Mol Cell | 2025 | 40972525 | PubTator, text mining | PubMed |
| Integrating COX-2, stromal PD-L1, and T-cell infiltration enhances prognostic stratification in colorectal cancer. | BMC Cancer | 2025 | 40958118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=7